These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21175546)

  • 1. Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method.
    Terawaki H; Yokoyama K; Yamada Y; Maruyama Y; Iida R; Hanaoka K; Yamamoto H; Obata T; Hosoya T
    Ther Apher Dial; 2010 Oct; 14(5):477-82. PubMed ID: 21175546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
    Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
    J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum uric acid and C-reactive protein levels in patients with chronic kidney disease].
    Caravaca F; Martín MV; Barroso S; Cancho B; Arrobas M; Luna E; Sánchez-Casado E
    Nefrologia; 2005; 25(6):645-54. PubMed ID: 16514905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
    Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
    Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-related systemic microinflammation is associated with specific genomic patterns.
    Zaza G; Pontrelli P; Pertosa G; Granata S; Rossini M; Porreca S; Staal FJ; Gesualdo L; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 2008 May; 23(5):1673-81. PubMed ID: 18048420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
    McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
    Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.
    Enia G; Panuccio V; Cutrupi S; Pizzini P; Tripepi G; Mallamaci F; Zoccali C
    Nephrol Dial Transplant; 2007 Feb; 22(2):538-44. PubMed ID: 17082213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
    Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
    QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of habitual physical activity in chronic haemodialysis patients.
    Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
    Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nutritional status, comorbidity, and inflammation in hemodialysis].
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
    Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevelamer decreases systemic inflammation in parallel to a reduction in endotoxemia.
    Stinghen AE; Gonçalves SM; Bucharles S; Branco FS; Gruber B; Hauser AB; Pecoits-Filho R
    Blood Purif; 2010; 29(4):352-6. PubMed ID: 20357435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients.
    Yamada K; Fujimoto S; Tokura T; Fukudome K; Ochiai H; Komatsu H; Sato Y; Hara S; Eto T
    Ren Fail; 2005; 27(4):361-5. PubMed ID: 16060120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.